Conditions: Healthy Volunteers
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 48
Healthy volunteers: yes

Brief summary:
The purpose of this study is to assess the oral bioavailability of Apixaban solution formulation (Treatment B, 10 mg as 25 mL x 0.4 mg/mL) relative to Apixaban tablets (Treatment A, 10 mg as 2 x 5 mg tablets) in healthy subjects.

Detailed description:

Arms:
arm 1: Apixaban Film coated Tablet Single dose 10 mg orally arm 2: Apixaban Solution Single dose 10 mg orally

Interventions: intervention 1: Apixaban
Intervention descriptions: intervention 1: None

Protocol document: